The analytes that have contributed to the separation belong to pathways or mechanisms previously known to be involved in the pathophysiology of the disease (e.g. neurotrophins in schizophrenia) or associated to comorbid states (e.g. insulin resistance in depression). This evidence concerns the gene BDNF and depressive symptom measurement.